AiViva Biopharma Receives New Patent ...Middle East

PR Newswire - News
AiViva Biopharma Receives New Patent
NEWPORT BEACH, Calif., Aug. 17, 2022 /PRNewswire/ -- AiViva Biopharma, a clinical stage biopharmaceutical company has received patent US 11,400,089 on August 2, 2022. This patent is a method of use patent for sGC stimulator and multikinase inhibitors to prevent and/or treat fibrosis...

Hence then, the article about aiviva biopharma receives new patent was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( AiViva Biopharma Receives New Patent )

Apple Storegoogle play

Last updated :

Also on site :